Condition

Candidiasis, Vulvovaginal (2)

Moniliasis, Vulvovaginal (2)

Mycoses (2)

Vaginitis, Monilial (2)

Yeast Infection (2)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Cidara Therapeutics Inc. (2)

Collaborator

Intervention

cd101 external gel (1%) (1)

cd101 external ointment (1%) (1)

cd101 vaginal gel (3%) (1)

cd101 vaginal ointment (6%) (1)

fluconazole (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (2)

Study Type

Interventional (1)

Observational (1)

moniliasis, vulvovaginal

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Candidiasis, Vulvovaginal, Mycoses, Yeast Infection Trial in United States (CD101 Vaginal Gel (3%), CD101 External gel (1%),

Completed

Candidiasis, Vulvovaginal
+4 more

CD101 Vaginal Gel (3%)
+4 more

Birmingham, Alabama
+23 more

Aug 21, 2020

Non-Interventional Extension to Investigate Recurrence of

Completed

Candidiasis, Vulvovaginal
+4 more

Phoenix, Arizona
+22 more

Feb 28, 2018